Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2013-05-29 Regulatory Filings
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB sluit langetermijnpartnerschap met UNITHER Pharmaceuticals voor productiefaciliteit in Rochester
Regulatory Filings Classification · 95% confidence The document is a press release dated May 29, 2013, announcing a strategic transaction: UCB entering a long-term partnership with UNITHER Pharmaceuticals regarding a manufacturing facility. It discusses asset transfer, supply agreements, and personnel changes. This type of announcement, detailing a significant business transaction (like an asset sale or major partnership), falls under the category of corporate actions that are not standard periodic financial reports (10-K, IR) or simple management/board changes (MANG). It is most closely related to Capital/Financing Updates (CAP) if it involves capital structure changes, or more generally, a significant corporate event announcement. Since it details a major operational/asset transaction and partnership, and does not fit the specific definitions for M&A (TAR - which usually implies a takeover/merger proposal), the best fit among the provided options for a significant, non-financial-results-focused corporate announcement is often the general Regulatory Filings (RNS) if no better fit exists, or potentially CAP if the transaction is viewed as restructuring capital deployment. However, given the nature of the announcement (asset transfer/partnership), and the lack of specific keywords for M&A (TAR), this is a material corporate event announcement. In many classification schemes, major asset disposals or strategic partnerships are often grouped under general regulatory announcements if a specific 'Corporate Transaction' code is missing. Given the options, and recognizing this is a material, non-periodic announcement, RNS (Regulatory Filings) serves as the most appropriate general category for significant, non-standard corporate news that isn't explicitly about financing (CAP) or management changes (MANG). It is a formal announcement ('gereglementeerde informatie').
2013-05-29 Dutch
Transparency notification of Capital May 2013 - ENG.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled a "Transparency notification" and explicitly states it concerns the disclosure of large shareholdings pursuant to Belgian law ("law of May 2, 2007 on the disclosure of large shareholdings"). It details that The Capital Group Companies Inc. has crossed a threshold (falling below 10%) regarding its ownership of UCB SA/NV shares. This type of filing, which reports changes in significant share ownership that cross statutory thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document length is relatively short (4347 chars), but its content is a direct notification of a change in ownership percentage, not merely an announcement that a report is available (which would suggest RPA or RNS).
2013-05-24 English
Transparency notification of Capital May 2013 - FR.pdf
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de transparence de The Capital Group Companies Inc." and explicitly references compliance with Article 6 of the law of May 2, 2007, regarding the disclosure of significant shareholdings ("publicité des participations importantes"). It details that The Capital Group Companies Inc.'s stake in UCB SA has fallen below a threshold, specifying the exact number of shares held (10%). This content directly corresponds to notifications about changes in significant share ownership, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). It is not an earnings release, a full annual report, or a general regulatory filing (RNS), as it concerns a specific insider/major shareholder transaction disclosure.
2013-05-24 French
Transparency notification of Capital May 2013 - NL.pdf
Major Shareholding Notification Classification · 98% confidence The document is a formal announcement ('Transparantieverklaring') issued on May 24, 2013, concerning a change in significant shareholding ('belangrijke deelnemingen') by The Capital Group Companies Inc. in UCB NV, referencing specific Belgian disclosure laws (Wet van 2 mei 2007). This type of filing specifically reports when an investor crosses or moves below a major ownership threshold (like 10%). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory disclosure, MRQ is a more specific category than the general RNS fallback.
2013-05-24 Dutch
Acquisition of own shares_ENG (09-05).pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition of own shares" and details several transactions involving the purchase and sale of UCB shares and options by the company itself (UCB SA/NV) over various dates in April and May 2013. This activity directly relates to the company managing its own stock, which falls under the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a detailed announcement, not just a link to a report, so RPA/RNS is not the primary classification.
2013-05-09 English
Acquisition of own shares_FR (09-05).pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres" (Acquisition of own shares) and details several transactions involving UCB SA buying back and selling its own shares (share swap transactions, OTC purchases/sales) on specific dates in April and May 2013. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. This matches Filing Type Code: POS (Transaction in Own Shares). The document is a detailed announcement, not just a notice of publication, and its length (6969 chars) suggests it contains the substance of the transaction details.
2013-05-09 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.